Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keytruda with Chemotherapy and Avastin in Advanced Cervical Cancer
NCT03367871Phase 2Terminated
- Sponsor
- University of Miami
- Start
- Sep 2018
- Primary completion
- Jan 2023
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pembrolizumab in Cervical Cancer (CC), sponsored by University of Miami. Started Sep 2018; status: terminated.
02
Drugs
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT03367871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03367871.